India, July 22 -- INDIAN ARMY has issued a tender notice titled "Corrigendum: Inj Ocrelizumab 300 Mg / 10 Ml,Inj Ofatumumab 20 Mg, Qty: 18" with the tender reference no.: GEM/2025/B/6274971.
The tender details are as follows: Inj Ocrelizumab 300 mg / 10 ml , Inj Ofatumumab 20 mg
The expression of interest should be received by Aug. 5.
For more information, contact INDIAN ARMY, Ministry Of Defence
Ministry of Defence|Department of Military Affairs
Kolkata, addlceo@gem.gov.in.
Disclaimer: Curated by HT Syndication....